Andreana, I.; Repellin, M.; Carton, F.; Kryza, D.; Briançon, S.; Chazaud, B.; Mounier, R.; Arpicco, S.; Malatesta, M.; Stella, B.;
et al. Nanomedicine for Gene Delivery and Drug Repurposing in the Treatment of Muscular Dystrophies. Pharmaceutics 2021, 13, 278.
https://doi.org/10.3390/pharmaceutics13020278
AMA Style
Andreana I, Repellin M, Carton F, Kryza D, Briançon S, Chazaud B, Mounier R, Arpicco S, Malatesta M, Stella B,
et al. Nanomedicine for Gene Delivery and Drug Repurposing in the Treatment of Muscular Dystrophies. Pharmaceutics. 2021; 13(2):278.
https://doi.org/10.3390/pharmaceutics13020278
Chicago/Turabian Style
Andreana, Ilaria, Mathieu Repellin, Flavia Carton, David Kryza, Stéphanie Briançon, Bénédicte Chazaud, Rémi Mounier, Silvia Arpicco, Manuela Malatesta, Barbara Stella,
and et al. 2021. "Nanomedicine for Gene Delivery and Drug Repurposing in the Treatment of Muscular Dystrophies" Pharmaceutics 13, no. 2: 278.
https://doi.org/10.3390/pharmaceutics13020278
APA Style
Andreana, I., Repellin, M., Carton, F., Kryza, D., Briançon, S., Chazaud, B., Mounier, R., Arpicco, S., Malatesta, M., Stella, B., & Lollo, G.
(2021). Nanomedicine for Gene Delivery and Drug Repurposing in the Treatment of Muscular Dystrophies. Pharmaceutics, 13(2), 278.
https://doi.org/10.3390/pharmaceutics13020278